Back
Eyenovia Vs. Reviva Pharmaceuticals Holdings Industry Stock Comparison
Buy
56
EYEN
Eyenovia
Last Price:
0.50
Seasonality Move:
31.56%
Sell
28
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.30
Seasonality Move:
-14.71%
Buy
56
Eyenovia (EYEN)
is a Buy
Is Eyenovia a Buy, Sell or Hold?
- The current Eyenovia [EYEN] share price is $0.46. The Score for EYEN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- EYEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Is Reviva Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.00. The Score for RVPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RVPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVPH Stock Price Chart
What is Reviva Pharmaceuticals Holdings's stock price today?
-
The Reviva Pharmaceuticals Holdings share price today is $1.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVPH is experiencing slight buying pressure.
EYEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 40.31 | Sell |
| Chaikin Money Flow: | -760765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.46 - 0.54) | Sell |
| Bollinger Bands (100): | (0.43 - 0.99) | Sell |
RVPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 41.67 | Sell |
| Chaikin Money Flow: | 118122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.99 - 1.31) | Sell |
| Bollinger Bands (100): | (0.96 - 1.32) | Sell |
EYEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.5 | Sell |
| 20-day SMA: | 0.52 | Sell |
| 50-day SMA: | 0.51 | Sell |
| 200-day SMA: | 0.93 | Sell |
| 8-day EMA: | 0.49 | Sell |
| 20-day EMA: | 0.51 | Sell |
| 50-day EMA: | 0.55 | Sell |
| 200-day EMA: | 0.92 | Sell |
RVPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.97 | Buy |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 2.06 | Sell |
| 8-day EMA: | 0.99 | Buy |
| 20-day EMA: | 1.09 | Sell |
| 50-day EMA: | 1.16 | Sell |
| 200-day EMA: | 1.97 | Sell |
Eyenovia Earnings Growth & EYEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.02 per share.
Reviva Pharmaceuticals Holdings Earnings Growth & RVPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.14 per share.
Eyenovia Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Reviva Pharmaceuticals Holdings Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||